Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own
Biotech stocks live and die on access to capital, so the Federal Reserve’s signal that interest rates may pause for now gives this high risk corner of the market some breathing room. Cheaper money can make it easier to fund drug pipelines and clinical trials, which matters if you are hunting for the next breakthrough. This article highlights three financially grounded biotech stocks that could potentially benefit from this environment. The three biotech stocks in focus below are just a small...
Biotech stocks live and die on access to capital, so the Federal Reserve’s signal that interest rates may pause for now gives this high risk corner of the market some breathing room. Cheaper money can make it easier to fund drug pipelines and clinical trials, which matters if you are hunting for the next breakthrough. This article highlights three financially grounded biotech stocks that could potentially benefit from this environment. The three biotech stocks in focus below are just a small...
What's Your Reaction?
